does retatrutide cause diabetes Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide—A Game Changer in Obesity

In 2018, the recommendations of the international evidence-based guidelines for the assessment and management of PCOS [1] indicated that, although its use is generally off label, metformin can be considered in addition to lifestyle in women with PCOS and Body Mass Index (BMI) 25 kg/m 2 to potentiate weight loss and to improve endocrine and metabolic outcomes

They are often prescribed to patients with type 2 diabetes who respond poorly to drugs such as metformin and sulfonylureas

doi: 10.1210/jendso/bvad056 [DOI] [PMC free article] [PubMed] [Google Scholar] 191

In the FIGHT study, the use of liraglutide was associated with an increased risk for rehospitalization for other cardiovascular reasons (HR 1.33

Ozempic and Wegovy are in a class of medications known as GLP-1 receptor agonists

Common side effects include nausea, dizziness, or diarrhoea, but these gastrointestinal (GI) side effects usually go away as your body gets used to the treatment